Ribosome-binding protein-1 (RRBP1) expression in prostate carcinomas and its relationship with clinicopathological prognostic factors
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Ribosome-binding protein-1 (RRBP1) is highly expressed in prostate cancer, particularly in high Gleason score (GS) tumors. Elevated RRBP1 levels may predict a poorer prognosis in prostate carcinoma patients.
Area Of Science
- Oncology
- Molecular Biology
- Biomarker Research
Background
- Ribosome-binding protein-1 (RRBP1) is increasingly recognized for its high expression in various cancers.
- RRBP1 shows potential as a prognostic biomarker in oncological studies.
- Understanding RRBP1's role in prostate cancer is crucial for developing new diagnostic and prognostic tools.
Purpose Of The Study
- To quantify RRBP1 expression in prostate carcinoma versus adjacent non-neoplastic tissue.
- To investigate the correlation between RRBP1 levels and established prognostic factors in prostate cancer.
- To elucidate the potential role of RRBP1 in the pathogenesis of prostate cancer.
Main Methods
- Analysis of RRBP1 expression in 45 prostatectomy specimens.
- Comparison of RRBP1 levels between tumoral and control tissues using Mann-Whitney U test.
- Statistical analysis, including hierarchical regression, to identify factors influencing RRBP1 expression.
Main Results
- Significantly higher mean and median RRBP1 expression levels were observed in tumors with a Gleason score (GS) of 8 or higher compared to those with GS less than 8.
- RRBP1 expression was found to be elevated in advanced-stage prostate cancer patients.
Conclusions
- Elevated RRBP1 expression is associated with higher Gleason scores and advanced stages in prostate carcinoma.
- RRBP1 may serve as a valuable predictive biomarker for the prognosis of prostate cancer.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Three of the best-understood negative regulators are p53, p21, and retinoblastoma protein (Rb). The regulatory roles of each of these proteins were discovered after faulty copies were found in cells with uncontrolled replication (i.e.,...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...